Cost impact of switching histamine(2)-receptor antagonists to nonprescription status

There is a recent trend to switching medications from prescription to nonprescription status. Often, such switches are accompanied by dramatic changes in utilization due to increased availability or decreased insurance coverage. The histamine(2)-receptor antagonists (H(2)RAs) underwent such status c...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Annals of pharmacotherapy 2002-07, Vol.36 (7), p.1135-1141
Hauptverfasser:	Furler, MD, Rolnick, MS, Lawday, KS, Mak, MW, Einarson, TR
Format:	Artikel
Sprache:	eng
Schlagworte:	Canada Gastrointestinal Agents - administration & dosage Gastrointestinal Agents - economics Histamine H2 Antagonists - administration & dosage Histamine H2 Antagonists - economics Humans Nonprescription Drugs - administration & dosage Nonprescription Drugs - economics Pharmacoepidemiology United Kingdom United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!